362 related articles for article (PubMed ID: 20727997)
1. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
Bellido T; Plotkin LI
Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs.
Plotkin LI; Manolagas SC; Bellido T
Bone; 2006 Sep; 39(3):443-52. PubMed ID: 16627025
[TBL] [Abstract][Full Text] [Related]
3. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.
Plotkin LI; Lezcano V; Thostenson J; Weinstein RS; Manolagas SC; Bellido T
J Bone Miner Res; 2008 Nov; 23(11):1712-21. PubMed ID: 18597631
[TBL] [Abstract][Full Text] [Related]
4. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
Plotkin LI; Bivi N; Bellido T
Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation.
Plotkin LI; Aguirre JI; Kousteni S; Manolagas SC; Bellido T
J Biol Chem; 2005 Feb; 280(8):7317-25. PubMed ID: 15590626
[TBL] [Abstract][Full Text] [Related]
6. Zoledronate promotes bone formation by blocking osteocyte-osteoblast communication during bone defect healing.
Cui P; Liu H; Sun J; Amizuka N; Sun Q; Li M
Histol Histopathol; 2018 Jan; 33(1):89-99. PubMed ID: 28345127
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice.
Watkins MP; Norris JY; Grimston SK; Zhang X; Phipps RJ; Ebetino FH; Civitelli R
Bone; 2012 Oct; 51(4):787-94. PubMed ID: 22750450
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies using non-traditional bisphosphonates.
Plotkin LI; Buvinic S; Balanta-Melo J
Bone; 2020 May; 134():115301. PubMed ID: 32112989
[TBL] [Abstract][Full Text] [Related]
9. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.
Bivi N; Condon KW; Allen MR; Farlow N; Passeri G; Brun LR; Rhee Y; Bellido T; Plotkin LI
J Bone Miner Res; 2012 Feb; 27(2):374-89. PubMed ID: 22028311
[TBL] [Abstract][Full Text] [Related]
10. Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis.
Zhou JZ; Riquelme MA; Gu S; Kar R; Gao X; Sun L; Jiang JX
Oncogene; 2016 Oct; 35(43):5597-5607. PubMed ID: 27041582
[TBL] [Abstract][Full Text] [Related]
11. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
Plotkin LI; Weinstein RS; Parfitt AM; Roberson PK; Manolagas SC; Bellido T
J Clin Invest; 1999 Nov; 104(10):1363-74. PubMed ID: 10562298
[TBL] [Abstract][Full Text] [Related]
12. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates and connexin 43: a critical review of evidence.
Sadr-Eshkevari P; Ashnagar S; Rashad A; Dietz M; Jackowski J; Abdulazim A; Prochnow N
Cell Commun Adhes; 2014 Oct; 21(5):241-7. PubMed ID: 24946183
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-induced, hemichannel-mediated, anti-apoptosis through the Src/ERK pathway: a gap junction-independent action of connexin43.
Plotkin LI; Bellido T
Cell Commun Adhes; 2001; 8(4-6):377-82. PubMed ID: 12064622
[TBL] [Abstract][Full Text] [Related]
15. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging.
Davis HM; Pacheco-Costa R; Atkinson EG; Brun LR; Gortazar AR; Harris J; Hiasa M; Bolarinwa SA; Yoneda T; Ivan M; Bruzzaniti A; Bellido T; Plotkin LI
Aging Cell; 2017 Jun; 16(3):551-563. PubMed ID: 28317237
[TBL] [Abstract][Full Text] [Related]
17. Role of connexin 43 in the mechanism of action of alendronate: dissociation of anti-apoptotic and proliferative signaling pathways.
Lezcano V; Bellido T; Plotkin LI; Boland R; Morelli S
Arch Biochem Biophys; 2012 Feb; 518(2):95-102. PubMed ID: 22230328
[TBL] [Abstract][Full Text] [Related]
18. Connexin 43 channels are essential for normal bone structure and osteocyte viability.
Xu H; Gu S; Riquelme MA; Burra S; Callaway D; Cheng H; Guda T; Schmitz J; Fajardo RJ; Werner SL; Zhao H; Shang P; Johnson ML; Bonewald LF; Jiang JX
J Bone Miner Res; 2015 Mar; 30(3):436-48. PubMed ID: 25270829
[TBL] [Abstract][Full Text] [Related]
19. Connexin 43 hemichannels and intracellular signaling in bone cells.
Plotkin LI
Front Physiol; 2014; 5():131. PubMed ID: 24772090
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K
Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
